Skip to main content
. 2017 Dec 22;8:1884. doi: 10.3389/fimmu.2017.01884

Figure 6.

Figure 6

Reverse cumulative distribution curves in participants receiving the 1790GAHB vaccine, following first (A) and second (B) vaccination compared with baseline and antibody levels in convalescent patient sera from individuals infected with Shigella sonnei. LPS, lipopolysaccharide; 1.5/25 μg, 5.9/100 μg, participants who received the 1790GAHB vaccine with an O antigen/protein content of 1.5/25 and 5.9/100 μg, respectively, at days 1 and 29; Convalescent, convalescent patient sera from 87 individuals infected with S. sonnei (20).